Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,225
datasets available to search
ShareScore release 0.9.0
Dataset results
2,225 results for “reversal”
Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts
ClinicalTrials.gov study NCT03621735. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)
ClinicalTrials.gov study NCT03351608. IPD Sharing: YES. Countries: 8. Publications: 1.
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
ClinicalTrials.gov study NCT00903682. IPD Sharing: Not stated. Countries: 11. Publications: 3.
Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery
ClinicalTrials.gov study NCT03939923. IPD Sharing: NO. Countries: 1. Publications: 12.
Effect of Neuromuscular Blockade and Reversal on Breathing
ClinicalTrials.gov study NCT02845375. IPD Sharing: YES. Countries: 1. Publications: 3.
Reversal Dabigatran Anticoagulant Effect With Idarucizumab
ClinicalTrials.gov study NCT02815670. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)
ClinicalTrials.gov study NCT03346057. IPD Sharing: YES. Countries: 4. Publications: 1.
Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis
ClinicalTrials.gov study NCT02455167. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Losartan to Reverse Sickle Nephropathy
ClinicalTrials.gov study NCT01479439. IPD Sharing: NO. Countries: 1. Publications: 1.
Quality of Recovery After Reversal With Neostigmine or Sugammadex.
ClinicalTrials.gov study NCT02909439. IPD Sharing: NO. Countries: 1. Publications: 3.
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
ClinicalTrials.gov study NCT03322657. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cholestasis Reversal: Efficacy of IV Fish Oil
ClinicalTrials.gov study NCT00910104. IPD Sharing: Not stated. Countries: 1. Publications: 11.
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
ClinicalTrials.gov study NCT01143246. IPD Sharing: NO. Countries: 2. Publications: 7.
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
ClinicalTrials.gov study NCT05794503. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alaf
ClinicalTrials.gov study NCT03631732. IPD Sharing: YES. Countries: 1. Publications: 1.
Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications
ClinicalTrials.gov study NCT03679611. IPD Sharing: NO. Countries: 1. Publications: 0.
Prediction of Development of Scapular Notching Following Reverse Total Shoulder Arthroplasty
ClinicalTrials.gov study NCT02052466. IPD Sharing: NO. Countries: 1. Publications: 1.
ALS Reversals - Lunasin Regimen
ClinicalTrials.gov study NCT02709330. IPD Sharing: YES. Countries: 1. Publications: 1.
Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Mainte
ClinicalTrials.gov study NCT01641809. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibito
ClinicalTrials.gov study NCT01448707. IPD Sharing: Not stated. Countries: 13. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.